Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Objectives
- ACIP immunization schedules
- First harmonized vaccine schedule
- Why do we use the schedules?
- 16 key recommendations from the ACIP
- Recommended immunization schedule (0-18 yrs)
- Hepatitis B
- Hepatitis B for infants - schedule
- Rotavirus vaccine
- Rotavirus vaccine - schedule
- Weekly rotavirus hospitalizations
- DTaP/Tdap
- DTaP/Tdap - schedule
- Unexpected consequences of a safer vaccine
- Tdap for pertussis recurrence
- Haemophilus influenzae type b
- Haemophilus influenzae type b - schedule
- Pneumococcal conjugate vaccine (PCV)
- PCV - schedule
- PCV7 - PCV13
- PCV7
- Inactivated polio vaccine (IPV)
- IPV - schedule
- Influenza vaccines - IIV/LAIV
- Influenza-associated pediatric deaths
- Influenza vaccines recommendations
- IIV vs. LAIV
- Influenza vaccine performance
- MMR
- Changing epidemiology of measles
- Measles, Mumps, Rubella
- Varicella
- Varicella - schedule
- Hepatitis A
- Hepatitis A vaccine - schedule
- Human Papilloma Virus (HPV)
- HPV4 and HPV2
- Female indication (HPV)
- Male indication (HPV)
- HPV effectiveness
- Meningococcal conjugate vaccine
- MCV4 - schedule
- Adolescent peak of meningococcal disease
- Recommended adult immunization schedule
- Influenza (adults)
- Benefit of maternal vaccination
- High dose influenza vaccine
- Td/Tdap (adults)
- Tdap - indications in adults
- Safety and efficacy of Tdap in pregnancy
- Herpes zoster in elders
- Herpes zoster vaccine - indications
- Post-licensure assessment for zoster vaccine
- PCV13/PPSV23
- PPSV23 Indications
- Revaccination with PPSV23
- PCV13 - immunocompromised adults
- PCV13 - adults 65+ years
- Routine PCV13 at age 65
- Final thoughts
- Evidence-based recommendations
- Vaccine are safe
- Vaccine are effective (1)
- Vaccine are effective (2)
- Summary points
Topics Covered
- Childhood and adult immunization schedules
- Routine, safe and highly effective preventive interventions
- Current recommendations
- Addressing new needs, new situations & emerging evidence
- Newly licensed vaccines and new indications
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Temte, J. (2015, May 28). Recommendations of the U.S. advisory committee on immunization practices [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 5, 2024, from https://doi.org/10.69645/OJLJ4688.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jonathan Temte has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Vaccines
Transcript
Please wait while the transcript is being prepared...
0:00
This is Doctor Jonathan Temte, professor of Family
Medicine at the University of
Wisconsin School of Medicine
and Public Health and chair
of the US Advisory Committee
on Immunization Practices.
Today, I will provide a
lecture on recommendations
of the US Advisory Committee
on immunization practices.
0:23
The objectives of my talk
include the following.
At the end, listeners will recognize
the ACIP immunization schedules.
We will review the current
ACIP recommendations
and include 16 key
recommendations, 12 of which
are for children and
adolescents and four for adults.
Finally, we will provide
some understanding
on the rationale and evidence
used for vaccine recommendations
in the United States.
0:60
The US Advisory Committee
on Immunization Practices
produces, on an annual schedule,
two schedules for vaccines.
We provide a schedule for
children from age zero
through 18 years and
a schedule for adults.
In addition, there is a
catch up schedule for people
who are lacking immunization.
And also, the footnotes that
accompany the schedules.
The footnotes are important
as they contain a vast amount
of information that will
help fill in any holes
that people have in
their understanding.
The schedules are
available on the website
that is shown on this slide.
Hide